PTGX

NASDAQ · Biotechnology

Protagonist Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$137.18

-6.19 (-4.32%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target -77.8% upside

Low Target $24.78

Average Target $30.47

High Target $49.57

Current Price $137.18

Current
$137.18

Target
$30.47

$24.78 $30.47 avg $49.57

Scenario Analysis

Bear Case

$24.78

-81.9%

Low target

Base Case

$30.47

-77.8%

Avg target

Bull Case

$49.57

+-63.9%

High target

Risk/Reward

0.8x

Unfavorable

Price in Context

52-Week High

$160.81

-14.7% from high

52-Week Low

$75.44

+81.8% from low

50-Day SMA

$142.20

-3.5% vs SMA

200-Day SMA

$117.49

+16.8% vs SMA

RSI (14)

59.6

Neutral

Target vs 52W High

$30.47

-81.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-10.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+116.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.2%
MRNA Moderna Inc	Hold	31	35%	$149.45	-38.1%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-60.7%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-35.8%